Beyond AI: Six startup opportunities in Europe
Six sectors where European expertise, needs and regulatory changes are opening up new markets.
Read on SubstackNeue große Buy-out-Fonds in Europa
37 Fonds mit First oder Final Close seit 1. Jan. 2025, insgesamt 133,3 Mrd. €, Median 2,1 Mrd. €.
Im vollständigen Tracker öffnen- 2.691,0
Advent's first dedicated mid-market vehicle, targeting smaller buyouts and growth investments with equity tickets of USD 100m to 350m and enterprise values up to USD 1.25bn.
- Advent International
- Business Services, Consumer, Health & Bio, Industrials
- Primarily North America and Europe
- USD
- Oktober 2026
- over USD 3bn (closed commitments to date)
- 24.215,0
Advent's 11th flagship global buyout fund, focused on Europe and North America, targeting complex corporate carve-outs and public-to-private transactions.
- Business Services, Consumer, Health & Bio, Industrials, Technology
- Europe and North America
- USD
- Fonds 11
- Oktober 2026
- close to USD 27bn (target USD 26bn)
- 7.000,0
- Bridgepoint
- Industrials, Business Services, Health & Bio, Technology
- Europe (European mid-market buyouts)
- Fonds 8
- Oktober 2026
- 1.500,0
Makes majority control investments in small-cap healthcare businesses alongside founders and families, driving international expansion, operational scaling and active buy-and-build.
- ARCHIMED
- Health & Bio
- not found
- Fonds 4
- September 2026
- 9.400,0
Ninth flagship buyout fund. Sector-focused investments in Technology, Consumer, Healthcare and Services, primarily in Europe and North America. Permira describes its Flagship strategy as control investing in the upper mid-market; this control wording is strategy-level evidence, not a separately verified IX-specific control quota.
- Permira
- Technology, Consumer, Health & Bio
- Primarily Europe and North America
- Fonds 9
- September 2026
- 2.300,0
Takes control positions in high-growth, asset-light European mid-market businesses in financial services, business services and TMT, applying sector expertise and operational capabilities.
- Cinven
- Business Services, Media & Telecom
- Pan-European
- Fonds 2
- September 2026
- 2.100,0
Builds market-leading Nordic mid-market businesses in stable sectors, working closely with management to drive profitable growth and operational transformation.
- Axcel
- Technology, Business Services, Industrials, Health & Bio, Consumer
- Nordics
- Fonds 8
- September 2026
- 1.100,0
Invests primarily through majority transactions in leading Italian entrepreneurial companies and industrial platforms.
- Nextalia Investment Management
- Generalist
- Southern Europe (Italy)
- Fonds 2
- August 2026
- 5.700,0
Makes majority investments in non-cyclical growth companies in healthcare, technology and payments and financial services, driving business transformation and earnings growth.
- Nordic Capital
- Health & Bio, Technology, Fintech
- Fonds 12
- Juli 2026
- 11.500,0
Flagship private equity fund investing across Europe and North America, with a strategy expected to be materially in line with EQT X.
- EQT
- Generalist
- Fonds 11
- Juli 2026
- 3.000,0
Invests sector-agnostically in high-quality, growth-oriented European mid-market businesses, providing operational expertise, strategic guidance and access to CVC's global network.
- CVC Capital Partners
- Generalist
- Pan-European
- Fonds 3
- Juli 2026
- 4.000,0
Invests in profitable B2B enterprise software and SaaS businesses, scaling them through organic growth and targeted acquisitions.
- Main Capital Partners
- B2B Software
- Primarily Western Europe and the Nordic region; North America also within manager's stated core geographies
- Fonds 9
- Juni 2026
Alle 37 Fonds auf dieser Seite
- Advent Mid-Market Private EquityAdvent International · €2.7bn reported · source published October 2026
- Advent International GPE XIAdvent International · €24.2bn reported · source published October 2026
- Bridgepoint Europe VIIIBridgepoint · €7.0bn reported · source published October 2026
- ARCHIMED MED IVARCHIMED · €1.5bn reported · source published September 2026
- Permira IXPermira · €9.4bn reported · source published September 2026
- Cinven Strategic Fund 2Cinven · €2.3bn reported · source published September 2026
- Axcel VIIIAxcel · €2.1bn reported · source published September 2026
- Nextalia Private Equity IINextalia Investment Management · €1.1bn reported · source published August 2026
- Nordic Capital XIINordic Capital · €5.7bn reported · source published July 2026
- EQT XIEQT · €11.5bn reported · source published July 2026
- CVC Catalyst IIICVC Capital Partners · €3.0bn reported · source published July 2026
- Main Capital IXMain Capital Partners · €4.0bn reported · source published June 2026
- Main Foundation IIIMain Capital Partners · €1.3bn reported · source published June 2026
- Charterhouse Capital Partners XIICharterhouse Capital Partners · €1.5bn reported · source published June 2026
- Norvestor X SCSpNorvestor · €2.0bn reported · source published June 2026
- Eurazeo PME VEurazeo · €1.0bn reported · source published May 2026
- Investindustrial Lower Mid-Market IVInvestindustrial · €1.5bn reported · source published April 2026
- Waterland Private Equity Fund XWaterland · €4.0bn reported · source published April 2026
- Triton Fund 6Triton Partners · €5.5bn reported · source published March 2026
- Inflexion Buyout Fund VIIInflexion · €4.5bn reported · source published March 2026
- H.I.G. Europe Capital Partners IVH.I.G. Capital · €1.6bn reported · source published January 2026
- Apheon MidCap Buyout VI SCSpApheon Management S.A. · €1.3bn reported · source published January 2026
- GHO Capital IVGHO Capital Partners · €2.5bn reported · source published October 2025
- Verdane Freya XIIVerdane · €2.0bn reported · source published September 2025
- Pollen Street Capital Fund VPollen Street Capital · €1.5bn reported · source published September 2025
- IK Small Cap IV FundIK Partners · €2.0bn reported · source published July 2025
- Exponent Private Equity Partners VExponent · €1.1bn reported · source published July 2025
- Marlin Heritage Europe IIIMarlin Equity Partners · €1.0bn reported · source published June 2025
- Ufenau VIII Asset Light SLPUfenau Capital Partners · €2.1bn reported · source published June 2025
- Thoma Bravo Europe FundThoma Bravo · €1.8bn reported · source published June 2025
- Egeria Private Equity Fund VIEgeria · €1.3bn reported · source published April 2025
- Investindustrial VIIIInvestindustrial · €4.0bn reported · source published April 2025
- IK X FundIK Partners · €3.3bn reported · source published April 2025
- Oakley Capital VIOakley Capital · €4.5bn reported · source published March 2025
- ICG Europe Mid-Market Fund IIICG · €3.0bn reported · source published March 2025
- Eurazeo Capital VEurazeo · €3.0bn reported · source published March 2025
- Adelis Equity Partners Fund IVAdelis Equity Partners · €1.6bn reported · source published March 2025
